Literature DB >> 14872458

Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity.

Graciela S Alarcón1, Gerald McGwin, Martha L Sanchez, Holly M Bastian, Barri J Fessler, Alan W Friedman, Bruce A Baethge, Jeffrey Roseman, John D Reveille.   

Abstract

OBJECTIVE: To determine the impact of wealth on disease activity in the multiethnic (Hispanic, African American, and Caucasian) LUMINA (Lupus in Minorities, Nature versus nurture) cohort of patients with systemic lupus erythematosus (SLE) and disease duration < or =5 years at enrollment.
METHODS: Variables (socioeconomic, demographic, clinical, immunologic, immunogenetic, behavioral, and psychological) were measured at enrollment and annually thereafter. Four questions from the Women's Health Initiative study were used to measure wealth. Disease activity was measured with the Systemic Lupus Activity Measure (SLAM). The relationship between the different variables and wealth was then examined. Next, the impact of wealth on disease activity was examined in regression models where the dependent variables were the SLAM score and SLAM global (physician). Variables previously found to impact disease activity plus the wealth questions were included in the models.
RESULTS: Questions on income, assets, and debt were found to distinguish patients into groups, wealthier and less wealthy. Less wealthy patients tended to be younger, women, noncaucasian, less educated, unmarried, less likely to have health insurance, and more likely to live below the poverty line. They also tended to have more active disease, more abnormal illness-related behaviors, less social support, and lower levels of self reported mental functioning. None of the wealth questions was retained in the regression models, although other socioeconomic features (such as African American ethnicity, poverty, and younger age) did.
CONCLUSIONS: Wealth, per se, does not appear to have an additional predictive value, over and above traditional measures of socioeconomic status, in SLE disease activity.

Entities:  

Mesh:

Year:  2004        PMID: 14872458     DOI: 10.1002/art.20085

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus.

Authors:  Chris Tonner; Laura Trupin; Jinoos Yazdany; Lindsey Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

Review 2.  Introduction/overview on clinical registries.

Authors:  D D Gladman; A Menter
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

3.  Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus.

Authors:  Edward Yelin; Jinoos Yazdany; Laura Trupin
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05-09       Impact factor: 4.794

4.  A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus.

Authors:  Joyce C Chang; Rui Xiao; Andrea M Knight; Stephen E Kimmel; Laura M Mercer-Rosa; Pamela F Weiss
Journal:  Semin Arthritis Rheum       Date:  2020-05-03       Impact factor: 5.532

5.  Interactions between patients, providers, and health systems and technical quality of care.

Authors:  Edward Yelin; Jinoos Yazdany; Chris Tonner; Laura Trupin; Lindsey A Criswell; Patricia Katz; Gabriela Schmajuk
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-03       Impact factor: 4.794

Review 6.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

7.  Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus.

Authors:  Jinoos Yazdany; JoAnn Zell Gillis; Laura Trupin; Patricia Katz; Pantelis Panopalis; Lindsey A Criswell; Edward Yelin
Journal:  Arthritis Rheum       Date:  2007-05-15

8.  Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus.

Authors:  A M Bertoli; L M Vilá; J D Reveille; G S Alarcón
Journal:  Ann Rheum Dis       Date:  2007-08-24       Impact factor: 19.103

Review 9.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

10.  Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).

Authors:  L B Tucker; A G Uribe; M Fernández; L M Vilá; G McGwin; M Apte; B J Fessler; H M Bastian; J D Reveille; G S Alarcón
Journal:  Lupus       Date:  2008-04       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.